WO2003059334A3 - Gemcitabine in the treatment of smallpox - Google Patents
Gemcitabine in the treatment of smallpox Download PDFInfo
- Publication number
- WO2003059334A3 WO2003059334A3 PCT/US2002/031570 US0231570W WO03059334A3 WO 2003059334 A3 WO2003059334 A3 WO 2003059334A3 US 0231570 W US0231570 W US 0231570W WO 03059334 A3 WO03059334 A3 WO 03059334A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gemcitabine
- smallpox
- treatment
- patient
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002365256A AU2002365256A1 (en) | 2001-10-25 | 2002-10-15 | Gemcitabine in the treatment of smallpox |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35662301P | 2001-10-25 | 2001-10-25 | |
US60/356,623 | 2001-10-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003059334A2 WO2003059334A2 (en) | 2003-07-24 |
WO2003059334A3 true WO2003059334A3 (en) | 2003-10-30 |
Family
ID=23402228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/031570 WO2003059334A2 (en) | 2001-10-25 | 2002-10-15 | Gemcitabine in the treatment of smallpox |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002365256A1 (en) |
WO (1) | WO2003059334A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117982522A (en) * | 2022-11-02 | 2024-05-07 | 河南真实生物科技有限公司 | Pharmaceutical use of nucleoside compound |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4808614A (en) * | 1983-03-10 | 1989-02-28 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
US4895937A (en) * | 1982-01-05 | 1990-01-23 | The Research Foundation Of State University Of New York | 5-ioso-2-pyrimidinone nucleoside |
US5837871A (en) * | 1989-05-15 | 1998-11-17 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
-
2002
- 2002-10-15 AU AU2002365256A patent/AU2002365256A1/en not_active Abandoned
- 2002-10-15 WO PCT/US2002/031570 patent/WO2003059334A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895937A (en) * | 1982-01-05 | 1990-01-23 | The Research Foundation Of State University Of New York | 5-ioso-2-pyrimidinone nucleoside |
US4808614A (en) * | 1983-03-10 | 1989-02-28 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
US5837871A (en) * | 1989-05-15 | 1998-11-17 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
Also Published As
Publication number | Publication date |
---|---|
AU2002365256A8 (en) | 2003-07-30 |
AU2002365256A1 (en) | 2003-07-30 |
WO2003059334A2 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1576963A3 (en) | Use of botulinum toxin in the treatment of pain due to an infection | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
MY113059A (en) | Controlled-release dosage forms of azithromycin | |
CA2334267A1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
AU1227302A (en) | System and method for optimizing drug therapy for the treatment of diseases | |
WO2003032994A3 (en) | Novel tri-substituted pyrimidines, method for production and use thereof as medicament | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
MXPA03000188A (en) | Methods of treating neutrophil-related diseases with topical anesthetics. | |
GB0130677D0 (en) | Medicaments and novel compounds | |
AU2000258352A1 (en) | Acupuncture points stimulation for treating various diseases | |
EP1525216A4 (en) | Combination therapy for treatment of hiv infection | |
WO2001054678A3 (en) | Combination therapy for cancer | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
WO2003059334A3 (en) | Gemcitabine in the treatment of smallpox | |
NZ512850A (en) | Treatment of papillomavirus infections | |
IL159770A0 (en) | Calcium salts with cytotoxic activity | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
WO2000010590A3 (en) | Cancer treatment | |
AU2450900A (en) | Therapeutic nucleoside compound | |
WO1999013894A3 (en) | Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c | |
AU1399100A (en) | Therapeutic treatment with immunogenic drugs | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2002356673B2 (en) | Medicament for the treatment of viral skin and tumor diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |